Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
20.92 USD | +2.96% | +30.38% | +39.99% |
05-02 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
05-02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.99% | 2.19B | |
+73.62% | 12.43B | |
-18.41% | 8.09B | |
-0.33% | 6.12B | |
+14.66% | 5.59B | |
-14.69% | 5.47B | |
+39.93% | 5.23B | |
-16.51% | 4.1B | |
-27.59% | 2.65B | |
+1.36% | 1.99B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Transcript : NovoCure Limited Presents at Piper Sandler 33rd Annual Virtual Healthcare Conference, Nov-30-2021 01